Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT
Background: Convulsive status epilepticus is the most common neurological emergency in children. Its management is important to avoid or minimise neurological morbidity and death. The current first-choice second-line drug is phenytoin (Epanutin, Pfizer Inc., New York, NY, USA), for which there is no...
Main Authors: | Richard E Appleton, Naomi EA Rainford, Carrol Gamble, Shrouk Messahel, Amy Humphreys, Helen Hickey, Kerry Woolfall, Louise Roper, Joanne Noblet, Elizabeth Lee, Sarah Potter, Paul Tate, Nadia Al Najjar, Anand Iyer, Vicki Evans, Mark D Lyttle |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2020-11-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/hta24580 |
Similar Items
-
Emergency treatment with levetiracetam or phenytoin in status epilepticus in children—the EcLiPSE study: study protocol for a randomised controlled trial
by: Mark D. Lyttle, et al.
Published: (2017-06-01) -
A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study
by: Stuart R. Dalziel, et al.
Published: (2017-06-01) -
Levetiracetam versus phenytoin in children with status epilepticus
by: Gowhar Wani, et al.
Published: (2019-01-01) -
Phenytoin versus Levetiracetam for Prevention of Early Posttraumatic Seizures: A Prospective Comparative Study
by: Kairav S. Shah, et al.
Published: (2015-11-01) -
Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
by: Hui-Qin Meng
Published: (2016-05-01)